Methods of using antibodies against human il-22

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/395 (2006.01) A61P 1/18 (2006.01) A61P 19/02 (2006.01) A61P 31/14 (2006.01) A61P 37/06 (2006.01) C07K 16/28 (2006.01)

Patent

CA 2642570

The present application provides human antibodies and antigen binding fragments thereof that specifically bind to the human interleukin-22 (IL-22) and methods of using those antibodies, for example, in diagnosing, treating or preventing inflammatory disorders, autoimmune diseases, allergies, septic shock, infectious disorders, transplant rejection, cancer, and other immune system disorders.

La présente invention concerne des anticorps humains et des fragments de liaison à l'antigène de ceux-ci liés de manière spécifique à l'interleukine-22 (IL-22) humaine, ainsi que des procédés d'utilisation desdits anticorps, par exemple, dans le diagnostic, le traitement ou la prévention de troubles inflammatoires, de maladies auto-immunes, d'allergies, d'un choc septique, de troubles infectieux, d'un rejet de transplant, du cancer, et d'autres troubles du système immunitaire.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Methods of using antibodies against human il-22 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of using antibodies against human il-22, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of using antibodies against human il-22 will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1637683

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.